OverviewChartNewsTraderScreen

BVT Knock-Out ABBV/  DE000VM6TDD3  /

EUWAX
2024-05-22  9:44:09 PM Chg.-0.35 Bid10:00:40 PM Ask10:00:40 PM Underlying Strike price Expiration date Option type
1.31EUR -21.08% -
Bid Size: -		 -
Ask Size: -		 AbbVie Inc 145.55 USD 2078-12-31 Call
GlobeNewswire 05-22 Over 130 Resident Dermatologists Receive In-Depth Cosmetic Training From Renowned ASDS Member Physic...
GlobeNewswire 05-22 Royalty Pharma and Cytokinetics Announce Expanded Strategic Funding Collaboration Totaling Up to $57...
GlobeNewswire 05-22 CytomX Therapeutics to Present at the Jefferies Global Healthcare Conference
GlobeNewswire 05-22 Cytokinetics and Royalty Pharma Announce Expanded Strategic Funding Collaboration Totaling Up to $57...
GlobeNewswire 05-22 Anavex Life Sciences Announces Expansion of Leadership Team
GlobeNewswire 05-22 OSE Immunotherapeutics and Boehringer Ingelheim expand collaboration to develop first-in-class treat...
GlobeNewswire 05-21 COUR Pharmaceuticals Appoints Paul M. Peloso, MD, as Chief Medical Officer
GlobeNewswire 05-21 BREAKING CEREVEL INVESTIGATION: BFA Law Is Investigating the $45 Per CERE (Nasdaq) Share Offer by Ab...
GlobeNewswire 05-21 Teva and Alvotech Announce SIMLANDI® (adalimumab-ryvk) Injection Now Available in the U.S.
GlobeNewswire 05-17 INVESTIGATION ANNOUNCEMENT: BFA Law Announces an Ongoing Investigation into the Merger between Cerev...
GlobeNewswire 05-16 CytomX Therapeutics Announces New Employment Inducement Grants
GlobeNewswire 05-16 Ventyx Biosciences Announces Appointment of Matthew Moore as Chief Operating Officer
GlobeNewswire 05-14 CEREVEL THERAPEUTICS HOLDINGS, INC. (NASDAQ: CERE) INVESTIGATION ALERT: Is $45 per CERE Share Enough...
GlobeNewswire 05-14 Pyxis Oncology Provides Corporate Update and Reports Financial Results for First Quarter 2024
GlobeNewswire 05-14 Nouscom Appoints Leading Cancer Drug Development Expert, Neil Gallagher, MD, PhD, as Independent Adv...
GlobeNewswire 05-14 In NCLA Amicus Win, and FTC Amicus Loss, Second Circuit Upholds Decision Dismissing Antitrust Suit
GlobeNewswire 05-13 Royalty Pharma to Present at Upcoming Investor Conferences
GlobeNewswire 05-11 SHAREHOLDER NOTICE: Halper Sadeh LLC Investigates LABP, DOMA, FXNC
GlobeNewswire 05-09 Coherus Announces Full Repayment of Pharmakon Advisors $75 Million Term Loan
GlobeNewswire 05-09 Royalty Pharma Reports First Quarter 2024 Results
GlobeNewswire 05-09 Royalty Pharma to Acquire Royalty Interest in Sanofi’s Frexalimab
GlobeNewswire 05-09 Nxera Pharma’s partner Neurocrine Biosciences Initiates Phase 1 Clinical Study Evaluating Effects of...
GlobeNewswire 05-08 CytomX Therapeutics Announces Positive Initial Phase 1a Dose Escalation Data for Monotherapy CX-904 ...
GlobeNewswire 05-08 CytomX Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update
GlobeNewswire 05-08 Alector Reports First Quarter 2024 Financial Results and Provides Business Update